hrcak mascot   Srce   HID

Pregledni rad

EPIDEMIOLOGICAL CHARACTERISTICS OF THYROID CANCER IN DALMATIA, CROATIA

NIKOLA KOLJA POLJAK ; University ENT Department, Split University Hospital Center , Split, Croatia
IVONA DIDOLIĆ ; School of Medicine, University of Split, Split, Croatia
ZAVIŠA ČOLOVIĆ ; University ENT Department, Split University Hospital Center, Split, Croatia
MIRKO KONTIĆ ; University ENT Department, Split University Hospital Center, Split, Croatia
IRIS JERONČIĆ ; Department of Public Health, School of Medicine, University of Split, Split, Croatia
ROSANDA MULIĆ ; Department of Public Health, School of Medicine, University of Split, Split, Croatia

Puni tekst: hrvatski, pdf (305 KB) str. 219-225 preuzimanja: 290* citiraj
APA 6th Edition
KOLJA POLJAK, N., DIDOLIĆ, I., ČOLOVIĆ, Z., KONTIĆ, M., JERONČIĆ, I. i MULIĆ, R. (2011). KARCINOM ŠTITNJAČE U DALMACIJI: NEKE EPIDEMIOLOŠKE OSOBITOSTI. Acta medica Croatica, 65 (3), 219-225. Preuzeto s https://hrcak.srce.hr/89153
MLA 8th Edition
KOLJA POLJAK, NIKOLA, et al. "KARCINOM ŠTITNJAČE U DALMACIJI: NEKE EPIDEMIOLOŠKE OSOBITOSTI." Acta medica Croatica, vol. 65, br. 3, 2011, str. 219-225. https://hrcak.srce.hr/89153. Citirano 20.10.2019.
Chicago 17th Edition
KOLJA POLJAK, NIKOLA, IVONA DIDOLIĆ, ZAVIŠA ČOLOVIĆ, MIRKO KONTIĆ, IRIS JERONČIĆ i ROSANDA MULIĆ. "KARCINOM ŠTITNJAČE U DALMACIJI: NEKE EPIDEMIOLOŠKE OSOBITOSTI." Acta medica Croatica 65, br. 3 (2011): 219-225. https://hrcak.srce.hr/89153
Harvard
KOLJA POLJAK, N., et al. (2011). 'KARCINOM ŠTITNJAČE U DALMACIJI: NEKE EPIDEMIOLOŠKE OSOBITOSTI', Acta medica Croatica, 65(3), str. 219-225. Preuzeto s: https://hrcak.srce.hr/89153 (Datum pristupa: 20.10.2019.)
Vancouver
KOLJA POLJAK N, DIDOLIĆ I, ČOLOVIĆ Z, KONTIĆ M, JERONČIĆ I, MULIĆ R. KARCINOM ŠTITNJAČE U DALMACIJI: NEKE EPIDEMIOLOŠKE OSOBITOSTI. Acta medica Croatica [Internet]. 2011 [pristupljeno 20.10.2019.];65(3):219-225. Dostupno na: https://hrcak.srce.hr/89153
IEEE
N. KOLJA POLJAK, I. DIDOLIĆ, Z. ČOLOVIĆ, M. KONTIĆ, I. JERONČIĆ i R. MULIĆ, "KARCINOM ŠTITNJAČE U DALMACIJI: NEKE EPIDEMIOLOŠKE OSOBITOSTI", Acta medica Croatica, vol.65, br. 3, str. 219-225, 2011. [Online]. Dostupno na: https://hrcak.srce.hr/89153. [Citirano: 20.10.2019.]

Sažetak
The causes of angioedema (AE), a self-limited, localized swelling of subcutaneous tissue or mucosa unaccompanied by urticaria, are diverse. The commonly applied label of “allergic” is frequently wrong and standard anti-allergic therapy can be ineffective. Types of AE could be categorized according to mediators which mediate vascular leakage: bradykinin AE (hereditary, acquired, angiotensin-converting enzyme inhibitor (ACEi)-related), histamine AE (allergic etiology), and various mediators mediated AE (pseudoallergic reaction to non-steroidal anti-inflammatory drugs). Idiopathic AE is a poorly understood syndrome. The growing relevance of AE without urticaria has been highlighted; angioedema is the most common cause of hospital admission among all acute allergic diseases. The diagnosis of AE is based on the presence of family history (hereditary), absence of family history with the onset during or after the fourth decade of life (acquired C1Inh deficiency), and treatment with ACEi (ACEi-related angioedema). About 0.1%-0.7% of patients taking ACEi develop angioedema as a well-documented but still frequently unrecognized side effect of drugs. Laboratory diagnosis is enabled by measuring serum levels of C1Inh antigen or C1Inh function. Type 1 (hereditary angioedema (HAE) was diagnosed when both antigenic and functional levels of C1Inh were below 50% of normal, and type 2 when functional levels of C1Inh were low, along with antigenic levels normal or higher. ACEi-related AE is diagnosed when AE recurs during therapy and disappears upon withdrawal. Symptoms may appear several years after therapy introduction. Severe acute attacks should be treated with C1Inh concentrate and icatibant, a selective and specific antagonist of bradykinin B2 receptors. Prophylaxis with attenuated androgens (danazol, stanazolol, oxandrolone) is effective in preventing symptom development.

Ključne riječi
thyroid cancer; epidemiology; Dalmatia; Croatia

Hrčak ID: 89153

URI
https://hrcak.srce.hr/89153

[hrvatski]

Posjeta: 1.325 *